Combination antiretroviral therapy: Overview
What it does
The job the technology does for people, in a short paragraph
Antiretroviral therapy keeps HIV, the virus that causes AIDS, from multiplying in the body. It does not cure the infection [6], but it lets people live long, healthy lives. The first drug was approved in 1987 and lasting combination treatment arrived in 1996 [1]. In 2025, 32.1 million people, 78% of everyone living with HIV, were receiving it [2].
as of 2026-11-11
How it works
The working principle in plain words, step by step
HIV carries its genes as RNA. Inside a human immune cell it uses its own enzyme, reverse transcriptase, to copy that RNA into DNA, then another enzyme, integrase, to splice the DNA into the cell's genome. The cell then makes new virus parts, which a third enzyme, protease, cuts into working form. Each class of antiretroviral drug blocks one of these steps [1]. HIV copies itself carelessly, so variants that resist any single drug soon appear. Using drugs from two or more classes at once means a variant would need several changes together to escape, which is very unlikely. That is why combinations hold the virus down for years [1].
as of 2026-11-11
Key figures
The handful of numbers that size it up, each with its unit, year and source
| Figure | Value | Unit | Year | Source |
|---|---|---|---|---|
| People receiving antiretroviral therapy | 32.1 | million people | 2025 | [2] |
| Share of people living with HIV on treatment | 78 | % | 2025 | [2] |
| Share of people living with HIV who are virally suppressed | 74 | % | 2025 | [2] |
| Fall in AIDS-related deaths since the 2004 peak | 73 | % | 2025 | [2] |
| Antiretroviral drugs available, more than (NIAID page, undated) | 30 | drugs | – | [1] |
as of 2026-11-11. UNAIDS figures are estimates with ranges (32.1 million: 28.2 to 33.4 million) [2]. The NIAID page gives no date, so the count of drugs carries no year [1].
Where it is used
The main places and products the technology is found in
- Lifelong treatment of people living with HIV
- Preventing transmission from mother to child
- National HIV programmes in low- and middle-income countries
- HIV clinics and primary care
- Prevention for people at high risk of infection
as of 2026-11-11
Scale today
How much of it there is now: units in use, made each year and who uses it
- Users
- 32.1 million people on treatment [2]
- Unit
- people
- Year
- 2025
- Note
- Of 41.0 million people living with HIV in 2025 [2].
as of 2026-11-11
Sources
- Antiretroviral Drug Discovery and Development National Institute of Allergy and Infectious Diseases (NIH)
- Fact sheet 2026 UNAIDS, 2026
- HIV and AIDS (fact sheet) World Health Organization, 2026